S. Cascio

发表

TP53 mutations and S‐phase fraction but not DNA‐ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma

A. Russo, S. Corsale, V. Agnese, 2006, Journal of cellular physiology.

TP 53 Mutations and S-Phase Fraction but not DNA-Ploidy Are Independent Prognostic Indicators in Laryngeal Squamous Cell Carcinoma

A. Russo, S. Corsale, V. Agnese, 2005 .

Increased Expression of Leptin and the Leptin Receptor as a Marker of Breast Cancer Progression: Possible Role of Obesity-Related Stimuli

A. Russo, S. Cascio, E. Surmacz, 2006, Clinical Cancer Research.

Laser pressure catapulting (LPC): Optimization LPC‐system and genotyping of colorectal carcinomas

A. Russo, S. Corsale, V. Agnese, 2005, Journal of cellular physiology.

Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration

S. Cascio, A. Farkas, O. Finn, 2013, Oncotarget.

Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1 alpha in human colorectal cancer.

A. Russo, S. Cascio, E. Surmacz, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Insulin-dependent leptin expression in breast cancer cells.

A. Russo, S. Cascio, E. Surmacz, 2008, Cancer research.

The estrogen receptor α:insulin receptor substrate 1 complex in breast cancer: structure–function relationships

S. Andò, A. Russo, S. Cascio, 2007 .

Intra- and Extra-Cellular Events Related to Altered Glycosylation of MUC1 Promote Chronic Inflammation, Tumor Progression, Invasion, and Metastasis

S. Cascio, O. Finn, 2016, Biomolecules.

Abnormally glycosylated MUC1 establishes a positive feedback circuit of inflammatory cytokines, mediated by NF-κB p65 and EzH2, in colitis-associated cancer

J. Lohmueller, S. Cascio, S. Ranganathan, 2017, Oncotarget.

MUC1 Protein Expression in Tumor Cells Regulates Transcription of Proinflammatory Cytokines by Forming a Complex with Nuclear Factor-κB p65 and Binding to Cytokine Promoters

S. Cascio, Lixin Zhang, O. Finn, 2011, The Journal of Biological Chemistry.

A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer

A. Russo, S. Corsale, V. Agnese, 2006, Breast Cancer Research and Treatment.

Cross-talk between Colon Cells and Macrophages Increases ST6GALNAC1 and MUC1-sTn Expression in Ulcerative Colitis and Colitis-Associated Colon Cancer

Jana G Hashash, S. Cascio, Natasa Miskov-Zivanov, 2019, Cancer Immunology Research.

Nuclear insulin receptor substrate 1 interacts with estrogen receptor α at ERE promoters

A. Vecchione, W. Miller, S. Cascio, 2004, Oncogene.

Complex of MUC1, CIN85 and Cbl in Colon Cancer Progression and Metastasis

S. Cascio, O. Finn, 2015, Cancers.

Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.

S. Corsale, V. Agnese, S. Cascio, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Nuclear insulin receptor substrate 1 interacts with estrogen receptor alpha at ERE promoters.

A. Vecchione, W. Miller, S. Cascio, 2004, Oncogene.

Functional Significance of Type 1 Insulin-like Growth Factor-mediated Nuclear Translocation of the Insulin Receptor Substrate-1 and β-Catenin*

S. Cascio, E. Surmacz, C. Garofalo, 2005, Journal of Biological Chemistry.

TP53 and p16INK4A, but not H‐KI‐Ras, are involved in tumorigenesis and progression of pleomorphic adenomas

A. Russo, S. Corsale, V. Agnese, 2006, Journal of cellular physiology.

Crosstalk between colon cells and macrophages increases ST6GALNAC1 and MUC1-sTn expression in ulcerative colitis and colitis-associated colon cancer

Finn, S. Cascio, D. Hartman, 2019 .

Founder mutations in BRCA1 and BRCA2 genes.

S. Cascio, E. Surmacz, V. Bazan, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses

A. Giordano, A. Russo, S. Corsale, 2007, Breast Cancer Research and Treatment.

Pharmacogenomics in colorectal carcinomas: Future perspectives in personalized therapy

A. Russo, S. Corsale, V. Agnese, 2005, Journal of cellular physiology.

Inflammation and Cancer

S. Cascio, O. Finn, P. Beatty, 2017 .

miR‐20b modulates VEGF expression by targeting HIF‐1α and STAT3 in MCF‐7 breast cancer cells

A. Russo, S. Cascio, E. Surmacz, 2010, Journal of cellular physiology.

Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features.

S. Cascio, F. Fulfaro, N. Gebbia, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Expression of nuclear insulin receptor substrate 1 in breast cancer

S. Andò, S. Cascio, E. Surmacz, 2006, Journal of Clinical Pathology.

Development of a pharmacologically improved peptide agonist of the leptin receptor.

R. Hoffmann, L. Otvos, J. Wade, 2008, Biochimica et biophysica acta.

14‐3‐3z sequesters cytosolic T‐bet, upregulating IL‐13 levels in TC2 and CD8+ lymphocytes from patients with scleroderma

Simon C Watkins, L. Moreland, T. Medsger, 2017, The Journal of allergy and clinical immunology.

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study.

D. Kerr, R. Lothe, V. Moreno, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Mechanism of leptin expression in breast cancer cells: role of hypoxia-inducible factor-1α

A. Giordano, A. Russo, S. Cascio, 2008, Oncogene.

Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells

A. Russo, S. Cascio, E. Surmacz, 2009, Journal of cellular physiology.

Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?

A. Russo, V. Agnese, S. Cascio, 2008, Breast Cancer Research and Treatment.

4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily).

A. Russo, V. Agnese, S. Cascio, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Tumor immunology: basic and clinical advances.

S. Cascio, Eric R. Lutz, P. Beatty, 2011, Cancer research.

Generation and characterization of humanized affinity-matured EGFL6 antibodies for ovarian cancer therapy.

S. Cascio, R. Buckanovich, Shoumei Bai, 2023, Gynecologic oncology.

Insulin-like Growth Factor 1 Differentially Regulates Estrogen Receptor-dependent Transcription at Estrogen Response Element and AP-1 Sites in Breast Cancer Cells*

A. Giordano, A. Russo, S. Cascio, 2006, Journal of Biological Chemistry.

The estrogen receptor alpha:insulin receptor substrate 1 complex in breast cancer: structure-function relationships.

S. Andò, A. Russo, S. Cascio, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Single-cell analysis reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of ovarian cancer

J. Mellors, H. Osmanbeyoglu, S. Cascio, 2023, bioRxiv.

MUC1 expression in tumor cells regulates transcription of proinflammatory cytokines by forming a complex with NF- κ B p65 and binding to cytokine promoters: importance of the extracellular domain

S. Cascio, Lixin Zhang, O. Finn, 2011 .

Agonists and partial antagonists acting on the leptin--leptin receptor interface.

L. Otvos, J. Wade, S. Cascio, 2009, Advances in experimental medicine and biology.

Ductal lavage: a way of carefully tracing the breast-secreting duct

A. Giordano, A. Russo, V. Agnese, 2006 .